Sveriges mest populära poddar

Delpharm CEO: Every Day Lost in Clinical Manufacturing Is a Day of Peak Sales Gone Forever

17 min•9 april 2026

“One day lost during a clinical phase is one day of peak sales that is lost — always.”

Nicolas Ragot, Chief Executive Officer of Delpharm, brings over three decades of pharmaceutical manufacturing expertise, having started his career as a process engineer at Eli Lilly before progressing through technical and leadership roles at Procter & Gamble Pharma and GSK. He joined Delpharm in 2018 as Chief Operating Officer and assumed the CEO role in 2024.

In this episode of the PharmaSource podcast, Nicolas explains why supply reliability, digital standardization, and long-term partnership thinking are the strategic pillars that allow Delpharm to differentiate in an increasingly consolidated CDMO market — and why time to market is the single most important criterion any biotech should use when selecting a manufacturing partner.

Fler avsnitt av PharmaSource Podcast

Decarbonizing Pharma: Why Green Chemistry Must Lead the Sustainability Agenda

18 maj•27 min

Kindeva's $200M Sterile Injectable Investment is Raising Compliance Standards

14 maj•17 min

How PI Health Sciences Delivers Real-Time Visibility and Scientific Accountability

11 maj•23 min

Navigating Chaos: Jan Ramakers on Why the API Market Is Harder to Read Than Ever

7 maj•34 min

How to Manage Molecule Uncertainty: Nick Wigdahl on Portfolio Optimization and Pharma Lifecycle Strategy

3 maj•22 min

IPSC Manufacturing: From Dolly the Sheep to Clinical-Grade Cell Therapies

30 apr.•38 min

Agentic AI x Pharma Manufacturing: Interview with Matt Lowe, Chief Strategy Officer, MasterControl

26 apr.•29 min

Oral Solid Dosage Manufacturing: Inside Rottendorf Pharma’s Strategic Alliance With Corealis Pharma

23 apr.•23 min

Combination Product Manufacturing: GLP-1 Hype, Talent Shortages, and the CDMO Shift

20 apr.•43 min

Novartis on What Great CDMO Partnerships Actually Look Like

16 apr.•22 min

PharmaSource Podcast med Life Science Networks finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.